Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Clinical trial NCT00113815 · COMPLETED

Trial details

NCT number: NCT00113815
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial Seizure Disorder Epilepsy Seizures

Start date: 2005-05-01
Primary completion: 2007-06-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.